Galectin Therapeutics
1 follower
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pat... Read more
Org chart
Joel Lewis
CEO & President
Joel Lewis
Collapse
Susan Thornton
VP, Regulatory Affairs
Ezra R. Lowe
VP, Clinical & Preclinical Pharmacology
Jeff Katstra
Head of CMC & Pharmaceutical Development
Sharisse Brutto
Director, Project Management
Seth Zuckerman
Senior Director, Biostatistics
Marla Mills-Wilson
Executive Director, Clinical Operations
Similar companies
Eagle Pharmaceuticals
1 follower
Mirum Pharmaceuticals
3 followers
Bristol-Myers Squibb
168 followers
Viatris
30 followers
Lundbeck
31 followers
Omnicell
20 followers
Syneos Health
17 followers
Catalent
14 followers
NYU Langone Health
12 followers
Nektar Therapeutics
7 followers
Confidence Pharmaceutical Research
1 follower
Discover companies